哮喘管理中全身性糖皮质激素使用的系统文献综述
该研究通过系统文献综述评估哮喘患者中口服/全身性糖皮质激素的真实使用程度及其负担。纳入139项研究,发现口服/全身性糖皮质激素在哮喘管理中普遍使用,且严重哮喘患者使用更频繁。长期和反复短期使用与急慢性不良事件风险增加相关,即使剂量较低,且累积剂量越大风险越高。
要点
- 口服/全身性糖皮质激素在哮喘管理中普遍使用,严重哮喘患者使用更频繁。
- 长期和反复短期使用与急慢性不良事件风险增加相关,即使剂量较低。
- 累积口服糖皮质激素剂量越大,急慢性并发症风险越高。
核心结论
- 口服/全身性糖皮质激素在哮喘管理中普遍使用,其急慢性并发症风险随累积口服剂量增加而升高。
研究设计与样本
- 系统文献综述,检索MEDLINE和Embase 2010-2017年英文文献,纳入观察性研究、处方数据库分析、经济分析和调查,最终纳入139项研究。
主要发现
- 口服/全身性糖皮质激素在哮喘管理中常用,严重哮喘患者使用更频繁。
- 长期使用较短期使用少见。
- 与未使用相比,长期和反复短期使用与急慢性不良事件风险增加相关,即使剂量较低。
- 口服/全身性糖皮质激素暴露增加与费用和医疗资源使用增加相关。
临床怎么用
- 临床应关注哮喘患者口服/全身性糖皮质激素的累积暴露,权衡获益与急慢性不良事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Systemic corticosteroid use to manage uncontrolled asthma and its associated healthcare burden may account for important health-related adverse effects. We conducted a systematic literature review to investigate the real-world extent and burden of systemic corticosteroid use in asthma. We searched MEDLINE and Embase databases to identify English-language articles published in 2010-2017, using search terms for asthma with keywords for oral corticosteroids and systemic corticosteroids. Observational studies, prescription database analyses, economic analyses, and surveys on oral/systemic corticosteroid use in children (>5 yr old), adolescents (12-17 yr old), and adults with asthma were included. We identified and reviewed 387 full-text articles, and our review included data from 139 studies. The included studies were conducted in Europe, North America, and Asia. Overall, oral/systemic corticosteroids were commonly used for asthma management and were more frequently used in patients with severe asthma than in those with milder disease. Long-term oral/systemic corticosteroid use was, in general, less frequent than short-term use. Compared with no use, long-term and repeated short-term oral/systemic corticosteroid use were associated with an increased risk of acute and chronic adverse events, even when doses were comparatively low. Greater oral/systemic corticosteroid exposure was also associated with increased costs and healthcare resource use. This review provides a comprehensive overview of oral/systemic corticosteroid use and associated adverse events for patients with all degrees of asthma severity and exposure duration. We report that oral/systemic corticosteroid use is prevalent in asthma management, and the risks of acute and chronic complications increase with the cumulative oral corticosteroid dosage.
引用
- Bleecker ER, Menzies-Gow AN, Price DB, et al. Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. Am J Respir Crit Care Med. 2020. PMID: 31525297. doi:10.1164/rccm.201904-0903SO
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。